Mustafa Asım Demirkol

ORCID: 0000-0001-6490-447X
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • COVID-19 Clinical Research Studies
  • Long-Term Effects of COVID-19
  • Chronic Obstructive Pulmonary Disease (COPD) Research
  • Respiratory Support and Mechanisms
  • Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
  • COVID-19 and healthcare impacts
  • COVID-19 diagnosis using AI
  • Ultrasound in Clinical Applications
  • Cystic Fibrosis Research Advances
  • Public Health and Nutrition
  • SARS-CoV-2 and COVID-19 Research
  • School Health and Nursing Education
  • Polyomavirus and related diseases
  • Lymphadenopathy Diagnosis and Analysis
  • Health and Wellbeing Research
  • Dermatological and COVID-19 studies
  • Immunodeficiency and Autoimmune Disorders
  • Health Systems, Economic Evaluations, Quality of Life
  • Autoimmune and Inflammatory Disorders Research
  • Non-Invasive Vital Sign Monitoring
  • Asthma and respiratory diseases
  • Diverse Approaches in Healthcare and Education Studies
  • Thermal Regulation in Medicine
  • Neonatal Respiratory Health Research
  • Sepsis Diagnosis and Treatment

İstanbul Başakşehir Çam ve Sakura Şehir Hastanesi
2023

Gaziosmanpaşa Taksim Eğitim ve Araştırma Hastanesi
2020-2022

Sağlık Bilimleri Üniversitesi
2020-2021

Yedikule Teaching Hospital
2018

The aim of the study was to analyze usefulness CURB-65 and pneumonia severity index (PSI) in predicting 30-day mortality patients with COVID-19, identify other factors associated higher mortality.A retrospective performed a pandemic hospital Istanbul, Turkey, which included 681 laboratory-confirmed COVID-19. Data on characteristics, vital signs, laboratory parameters were recorded from electronic medical records. Receiver operating characteristic analysis used quantify discriminatory...

10.1016/j.ijid.2020.06.038 article EN cc-by-nc-nd International Journal of Infectious Diseases 2020-06-14

Due to current advances and growing experience in the management of coronavirus Disease 2019 (COVID-19), outcome COVID-19 patients with severe/critical illness would be expected better second wave compared first wave. As our hospitalization criteria changed wave, we aimed investigate whether a favorable occurred hospitalized only illness. Among 642 laboratory-confirmed 1121 those who met World Health Organization (WHO) definitions for severe or critical on admission during follow-up were...

10.1002/jmv.27319 article EN Journal of Medical Virology 2021-09-07

In this study, laboratorial parameters of hospitalized novel coronavirus (COVID-19) patients, who were complicated with severe pneumonia, compared the findings cytokine storm developing in macrophage activation syndrome (MAS)/secondary hemophagocytic lymphohistiocytosis (sHLH). Severe pneumonia occurred as a result some patients needed intensive care unit (ICU), and it is aimed to determine precursive situation. Also aim identify laboratory criteria that predict worsening disease ICU...

10.1002/jmv.27068 article EN Journal of Medical Virology 2021-05-09

BackgroundThe clinical spectrum of COVID-19 has a great variation from asymptomatic infection to acute respiratory distress syndrome and eventually death. The mortality rates vary across the countries probably due heterogeneity in study characteristics patient cohorts as well treatment strategies. Therefore, we aimed summarize outcomes adult patients hospitalized with laboratory-confirmed pneumonia Istanbul, Turkey.MethodsA total 722 were analyzed this single-center retrospective between...

10.1016/j.jiac.2020.10.020 article EN other-oa Journal of Infection and Chemotherapy 2020-10-23

Organizing pneumonia following ocrelizumab use in a patient with multiple sclerosis: A case reportOcrelizumab is an anti-CD20 monoclonal antibody used the treatment of primary progressive and relapsing sclerosis (MS).Although cases organizing have been reported association other agents such as rituximab, there insufficient data literature on Ocrelizumab-associated lung involvement.Herein, we present 37-year-old female Ocrelizumab use.

10.5578/tt.20239913 article EN Tuberkuloz ve Toraks 2023-03-10

Domiciliary noninvasive mechanical ventilation (NIMV) is used for treating patients with hypercapnic chronic obstructive pulmonary disease (COPD). We aimed to evaluate the association between adherence treatment and subsequent hospitalizations costs. Data from 54 (27 adherent; 27 non-adherent) COPD who were undergoing NIMV at home 6 months. assessed based on digitally recorded data checked hospital records clinical laboratory data, rehospitalization rates, costs during following Nocturnal...

10.1080/15412555.2018.1500532 article EN COPD Journal of Chronic Obstructive Pulmonary Disease 2018-05-04

Background: Effective triage and early detection are very important for the control treatment of coronavirus disease 2019. For this purpose, reverse transcription polymerase chain reaction chest computed tomography used in emergency departments. Objective: The aim study was to examine diagnostic performance compare inter-observer agreement among radiologists between clinicians, a 2019 pneumonia high-prevalence area. Methods: After exclusions, 534 patients were retrospectively included study....

10.1177/1024907920968648 article EN cc-by-nc-nd Hong Kong Journal of Emergency Medicine 2020-10-28

Defining the optimal therapeutic approach in patients with chronic obstructive pulmonary disease (COPD) bronchiectasis overlap (CBO) is challenging. The presence of emphysema suggests that COPD primary problem and it impacts decision making.We hypothesized AreaFE% performance will be reliable diagnosing such serial CT scanning may not needed. In this retrospective chart review study, we included 113 CBO (52 having emphysema, 61 emphysema). We compared these two groups according to...

10.1080/17476348.2020.1766972 article EN Expert Review of Respiratory Medicine 2020-05-07

Sir, Digital pulse oximetry is a rapid noninvasive test and used to estimate arterial oxygen saturation. However, falsely low readings are common due range of causes including motion artifact, hypotension, nail polish, darker skin pigmentation, venous pulsations. We recently encountered number patients with coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome 2 (SARS-CoV-2) saturation detected digital oximetry. Following the first confirmed COVID-19 case on March...

10.4103/lungindia.lungindia_392_20 article EN cc-by-nc-sa Lung India 2020-01-01

COVID-19 is a disease associated with diffuse lung injury that has no proven effective treatment yet. It thought glucocorticoids may reduce inflammation-mediated injury, progression, and mortality. We aimed to evaluate our patient's characteristics outcomes who received corticosteroids for pneumonia.We conducted multicenter retrospective study reviewed 517 patients admitted due pneumonia were hypoxemic administered steroids regarding demographic, laboratory, radiological characteristics,...

10.1080/17476348.2022.2102480 article EN Expert Review of Respiratory Medicine 2022-07-15

<b>Background:</b> Non-cystic fibrosis bronchiectasis(non-CF BE) continues to be important disease because of the fact that it disrupts quality life patients <b>Aim:</b> Our aim is evaluate relationship between (QOL) and radiologic findings in non-CF BE also examine risk factors associated with QOL <b>Methods:</b> 71 bronchiectasis were included this study. All completed Short-Form-36(SF-36), St. George's Questionnaire (SGRQ) assessed by using Modified Bhalla Score(MBS). <b>Results:</b>...

10.1183/13993003.congress-2018.pa353 article EN 2018-09-15

<b>Background:</b> Domiciliary Noninvasive mechanical ventilation (NIMV) is used in the treatment of severe hypercapnic COPD patients. Our aim to evaluate relationship between adherence domiciliary noninvasive ventilation, subsequent hospitalization and their hospital costs patients with COPD. <b>Material-Method:</b> 54 (27 adherent) who were getting undergoing NIMV at home for 6 months taken included study. Their compliance examined by using based on data from SD card re-hospitalization...

10.1183/13993003.congress-2018.pa2367 article EN 2018-09-15

<b>Aim:</b> Evidences showed that coronavirus disease 2019 (COVID-19) can cause increased coagulopahty due to many different mechanisms. We aimed identfy features of patients newly diagnosed pulmonary embolism (PE) during COVID pneumonia and evaluate prognosis those patients. <b>Method:</b> conducted a multicenter retrospective study examined files who was with PE within 45 days after or at the same time diagnosis pneumonia. <b>Results:</b> 38 (36,9%) women mean age 59,8 years. 47 (45,6%)...

10.1183/13993003.congress-2021.pa498 article EN 2021-09-05
Coming Soon ...